Oral News and Research

RSS

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 – June 3, 2014.

31 May 2014

Northwestern Medicine allergist offers tips to fight allergies

Nasal congestion, sneezing, and itchy and watery eyes — for the nearly 50 million Americans with seasonal allergies, these are the true rites of spring

31 May 2014

Tom's of Maine offers new natural Toddler Training Toothpaste to help start good brushing habits

A baby's first smile is a moment to treasure. Keeping that grin healthy makes parents smile, too. Tom's of Maine, the leading natural oral care brand, is offering parents a new natural Toddler Training Toothpaste to help start good brushing habits with no artificial flavors, sweeteners, preservatives or dyes.

31 May 2014

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration.

31 May 2014

Dentists’ awareness can improve oral health of scleroderma patients

A survey of dentists in Massachusetts suggests that their confidence in treating patients with scleroderma may be related to their familiarity with the autoimmune disease.

30 May 2014

Study shows high BP drugs may raise likelihood of age-related macular degeneration

There may be a connection between taking vasodilators and developing early-stage age-related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older, according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

29 May 2014

Noninvasive laser therapy triggers stem cells to repair enamel of teeth

A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.

29 May 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

CytRx announces Phase 2b clinical trial results of aldoxorubicin in subjects with metastatic STS

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.

28 May 2014

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.

28 May 2014

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women.

27 May 2014

Research to better understand cell defect that contributes to cancer

A research team from Plymouth University Peninsula Schools of Medicine and Dentistry has received funding from the Biotechnology and Biological Sciences Research Council for research to better understand a cell defect that contributes to diseases such as cancer.

26 May 2014

American Association of Diabetes Educators suggests tips for safe travel

AAA estimates 36.1 million people will travel this Memorial Day weekend. If diabetes is your constant companion, that doesn't mean you can't enjoy traveling, whether traversing America in an RV or flying to the far reaches of the globe. Ensuring you stay healthy and keep your glucose levels on an even keel does require a little bit of organization and planning ahead, though.

23 May 2014

Gastroenterologists select efficacy over safety, tolerability when prescribing new drug for Crohn's disease

Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.

22 May 2014

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.

22 May 2014

Agios Pharmaceuticals to present AG-221 Phase 1 study results at EHA meeting

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEMs), today announced that new clinical data from the Phase 1 study of AG-221, an orally available, selective, potent inhibitor of the mutated IDH2 protein, will be highlighted in an oral presentation at the 19th Congress of the European Hematology Association (EHA) taking place June 12 -15, 2014 in Milan, Italy.

22 May 2014

Erlotinib, gefitinib have similar efficacy in NSCLC patients with EGFR mutation

Disease progression-free survival is similar for patients with non-small-cell lung cancer and epidermal growth factor receptor mutations whether they receive erlotinib or gefitinib, show the results of a South Korean study.

21 May 2014

69% of healthy American adults are infected with 109 strains of human papillomavirus

In what is believed to be the largest and most detailed genetic analysis of its kind, researchers at NYU Langone Medical Center and elsewhere have concluded that 69 percent of healthy American adults are infected with one or more of 109 strains of human papillomavirus (HPV).

21 May 2014

Low physical activity, heavy use of electronic media linked to increased health risk in children

The Physical Activity and Nutrition in Children Study, PANIC, carried out by the Institute of Biomedicine at the University of Eastern Finland shows that low levels of physical activity combined with heavy use of electronic media and sedentary behaviour are linked to an increased risk for type 2 diabetes and vascular diseases already in 6-8 year-old children.

20 May 2014

Vandetanib delays disease progression in elderly NSCLC patients

Vandetanib used in combination with gemcitabine significantly improves progression-free survival compared with gemcitabine alone when used as a first-line treatment for elderly patients with advanced non-small-cell lung cancer, Italian researchers report.

19 May 2014

Oral News and Research

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Northwestern Medicine allergist offers tips to fight allergies

Tom's of Maine offers new natural Toddler Training Toothpaste to help start good brushing habits

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Dentists’ awareness can improve oral health of scleroderma patients

Study shows high BP drugs may raise likelihood of age-related macular degeneration

Noninvasive laser therapy triggers stem cells to repair enamel of teeth

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

CytRx announces Phase 2b clinical trial results of aldoxorubicin in subjects with metastatic STS

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

Research to better understand cell defect that contributes to cancer

American Association of Diabetes Educators suggests tips for safe travel

Gastroenterologists select efficacy over safety, tolerability when prescribing new drug for Crohn's disease

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Agios Pharmaceuticals to present AG-221 Phase 1 study results at EHA meeting

Erlotinib, gefitinib have similar efficacy in NSCLC patients with EGFR mutation

69% of healthy American adults are infected with 109 strains of human papillomavirus

Low physical activity, heavy use of electronic media linked to increased health risk in children

Vandetanib delays disease progression in elderly NSCLC patients

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News